Baron Silver Stevens Financial Advisors LLC Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Baron Silver Stevens Financial Advisors LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 71.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,025 shares of the healthcare conglomerate’s stock after purchasing an additional 427 shares during the quarter. Baron Silver Stevens Financial Advisors LLC’s holdings in UnitedHealth Group were worth $320,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 50 shares during the period. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group during the first quarter valued at approximately $42,000. Kentucky Trust Co boosted its position in UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Finally, O Brien Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE:UNH opened at $344.15 on Monday. The stock has a 50 day moving average price of $301.20 and a 200 day moving average price of $358.73. The stock has a market cap of $311.69 billion, a PE ratio of 14.91, a P/E/G ratio of 2.24 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the business earned $6.80 earnings per share. The firm’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. KeyCorp decreased their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Bank of America upped their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research note on Monday, August 18th. Barclays lifted their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Finally, Morgan Stanley raised their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.